Champions Oncology, Inc. (CSBR)
7.21
+0.04
(+0.52%)
USD |
NASDAQ |
Jan 16, 16:00
7.14
-0.07
(-0.97%)
After-Hours: 20:00
Champions Oncology Profit Margin (Quarterly): 1.58% for Oct. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -12.63K% |
| Perspective Therapeutics, Inc. | -12.43K% |
| Protalix Biotherapeutics, Inc. | 13.19% |
| Electromed, Inc. | 12.65% |
| Armata Pharmaceuticals, Inc. | -2.30K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 68.71% |
| Return on Assets | 8.16% |
| Return on Invested Capital | 24.74% |
| Gross Profit Margin (Quarterly) | 49.32% |
| Operating Margin (Quarterly) | 1.23% |
| Return on Net Operating Assets | 10.75% |